This company has been acquired
Resumen de acción EMHT.F
Emerald Health Therapeutics, Inc., together with its subsidiaries, engages in the production, distribution, and sale of recreational and medical cannabis in Canada.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Competidores de Emerald Health Therapeutics, Inc.
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.041 |
| 52 Week High | CA$0.086 |
| 52 Week Low | CA$0.02 |
| Beta | 0.63 |
| 1 Month Change | 35.00% |
| 3 Month Change | 6.92% |
| 1 Year Change | -49.38% |
| 3 Year Change | -89.05% |
| 5 Year Change | -97.80% |
| Change since IPO | -89.26% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| EMHT.F | US Pharmaceuticals | Mercado US | |
|---|---|---|---|
| 7D | 19.5% | 2.3% | 1.6% |
| 1Y | -49.4% | 10.8% | 25.1% |
Rentabilidad vs. Industria: EMHT.F underperformed the US Pharmaceuticals industry which returned 4% over the past year.
Rentabilidad vs. Mercado: EMHT.F underperformed the US Market which returned -21.4% over the past year.
Volatilidad de los precios
| EMHT.F volatility | |
|---|---|
| EMHT.F Average Weekly Movement | 21.2% |
| Pharmaceuticals Industry Average Movement | 10.2% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Precio estable de las acciones: EMHT.F's share price has been volatile over the past 3 months.
Volatilidad a lo largo del tiempo: EMHT.F's weekly volatility (21%) has been stable over the past year, but is still higher than 75% of US stocks.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| n/a | 111 | n/a | emeraldhealth.ca |
Resumen de fundamentos de Emerald Health Therapeutics, Inc.
| Estadísticas fundamentales de EMHT.F | |
|---|---|
| Capitalización bursátil | US$5.62m |
| Beneficios(TTM) | -US$21.20m |
| Ingresos (TTM) | US$5.36m |
1.0x
Ratio precio-ventas (PS)-0.3x
Ratio precio-beneficio (PE)¿Está EMHT.F sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de EMHT.F | |
|---|---|
| Ingresos | CA$7.13m |
| Coste de los ingresos | CA$12.67m |
| Beneficio bruto | -CA$5.54m |
| Otros gastos | CA$22.64m |
| Beneficios | -CA$28.18m |
Últimos beneficios comunicados
Jun 30, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.13 |
| Margen bruto | -77.71% |
| Margen de beneficio neto | -395.33% |
| Ratio deuda/patrimonio | 0% |
¿Cómo se ha desempeñado EMHT.F a largo plazo?
Ver rendimiento histórico y comparativa